NewRegen, Inc.

Equities

NREG

US85179A1034

Healthcare Facilities & Services

Delayed OTC Markets Other stock markets 02:39:49 2024-05-01 pm EDT			5-day change	1st Jan Change
0.0125 ^USD	+38.89%		+32.98%	-26.47%

Jan. 12	PickleJar Entertainment Group Announces Launch of its Digital Marketing Services Solution, FanVivo	CI
2023	NewRegen, Inc. Announces Resignation of Everett Dickson as Director	CI

Avra, Inc. Announces 2022 Expansion, Plans Rapid Expansion of Clinics in Us

January 18, 2022 at 08:00 am EST

Avra Inc. recently merged with Springs Rejuvenation, (Spring), a Chamblee, Georgia based anti-aging and stem cell center focusing on stem cell therapy. Following a successful merger, Avra currently operating “Springs Rejuvenation” (“Springs”) (The Company) announced the plans to open 8 new clinics strategically located in the United States. Targeted cities/regions include Miami, Austin, New York City, Denver CO, Phoenix, Southern California, The Great Lakes Region, and the Midwest.

Latest news about NewRegen, Inc.

PickleJar Entertainment Group Announces Launch of its Digital Marketing Services Solution, FanVivo	Jan. 12	CI
NewRegen, Inc. Announces Resignation of Everett Dickson as Director	Nov. 27	CI
PickleJar Holdings, Inc. acquired NewRegen, Inc. in a reverse merger transaction.	Nov. 26	CI
NewRegen, Inc. Widens Expansion Plans of Geographic Markets With Strategic Partner Marketing Program	23-06-27	CI
Springs Rejuvenation, LLC cancelled the acquisition of Avra Inc. in a reverse merger transaction.	22-09-20	CI
AVRA, Inc. has Changed its Name to Springs Rejuvenation Inc	22-03-09	CI
Avra, Inc Expands Atlanta Operations	22-03-02	CI
Avra, Inc. Signs Lease For New Fort Lauderdale FL Clinic Location	22-01-24	CI
Avra, Inc. Announces 2022 Expansion, Plans Rapid Expansion of Clinics in Us	22-01-18	CI
Springs Rejuvenation, LLC has signed an letter of intent to acquire Avra Inc. in a reverse merger transaction.	21-10-28	CI
Avra Inc. Reports Earnings Results for the Full Year Ended January 31, 2019	19-06-21	CI
Avra Inc. Reports Earnings Results for the Third Quarter Ended October 31, 2018	19-02-04	CI
Avra, Inc. Announces the Introduction of AvraSecure	15-04-20	CI
Avra Appoints Vasiliy Smetanin as Vice President of ATM and Kiosk Operations	15-01-20	CI
Avra, Inc. Appoints Mr. Mark Petropolous to the Position of Vice President of Sales for North America	15-01-08	CI
Avra Inc. Finalizes Technology Partnership with T2M International Inc	14-12-31	CI
Avra Inc. Enters Letter of Intent with Mango Pay SRL to Launch Digital Currency in Carribbean	14-12-05	CI
Avra Inc. announced that it has received $0.15 million in funding.	14-12-04	CI
Chief Executive Officer and Director of the Avra, Stephen Shepherd, acquired 56.27% stake in Avra Inc. from David Bailey for $0.06 million.	14-11-30	CI
Avra Inc. will Change its Ticker to AVRN from AVRND	14-07-22	CI
Avra Inc. will Change its Ticker to AVRND from AVRN	14-06-23	CI
Avra Inc. Announces Executive Changes	14-06-05	CI
Avra Inc. will Change its Ticker to AVRNE from AVRN	13-03-22	CI

Chart NewRegen, Inc.

Duration

Period

More charts

Company Profile

Newregen, Inc. provides anti-aging and regenerative medical treatments. It operates two brick and mortar and one Affiliated clinic. These are located in Atlanta, GA, Ft Lauderdale, FL and Tupelo MS. Its treatments have shown outcomes in autoimmune, inflammatory, neurological, and orthopedic conditions, injuries and other chronic pains. It is also focused on expanding its operations in FL and GA by adding additional affiliate clinics. It offers various services, including hormone replacement therapy, allograft suspension (stem cell) therapy, longevity, immunity, testosterone replacement therapy, weight management and others. It also offers multiple forms of hormone therapy, peptide therapy, cellular therapy, and other wellness therapies that complement their core services. The hormone replacement therapy treats a range of naturally occurring symptoms, including weight gain, increased body fat/decreased muscle mass, low energy, hair loss and others. Its subsidiary is ReGenMD, Inc.

Sector

Healthcare Facilities & Services

More about the company

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
NEWREGEN, INC.	-26.47%	792K
HCA HEALTHCARE, INC.	+14.37%	81.84B
CVS HEALTH CORPORATION	-30.43%	70.69B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+9.37%	29.03B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-12.07%	16.97B
FRESENIUS SE & CO. KGAA	-0.36%	16.83B
QUEST DIAGNOSTICS INCORPORATED	-1.33%	15.28B
FRESENIUS MEDICAL CARE AG	+5.90%	12.41B
DAVITA INC.	+36.27%	12.26B
EUROFINS SCIENTIFIC SE	-4.20%	11.86B

Other Healthcare Facilities & Services